Gut and Liver (Sep 2024)
Corrigendum to: The Association between Educational Attainment and the Risk of Nonalcoholic Fatty Liver Disease among Chinese Adults: Findings from the REACTION Study
- Yuanyue Zhu,
- Long Wang,
- Lin Lin,
- Yanan Huo,
- Qin Wan,
- Yingfen Qin,
- Ruying Hu,
- Lixin Shi,
- Qing Su,
- Xuefeng Yu,
- Li Yan,
- Guijun Qin,
- Xulei Tang,
- Gang Chen,
- Shuangyuan Wang,
- Hong Lin,
- Xueyan Wu,
- Chunyan Hu,
- Mian Li,
- Min Xu,
- Yu Xu,
- Tiange Wang,
- Zhiyun Zhao,
- Zhengnan Gao,
- Guixia Wang,
- Feixia Shen,
- Xuejiang Gu,
- Zuojie Luo,
- Li Chen,
- Qiang Li,
- Zhen Ye,
- Yinfei Zhang,
- Chao Liu,
- Youmin Wang,
- Shengli Wu,
- Tao Yang,
- Huacong Deng,
- Lulu Chen,
- Tianshu Zeng,
- Jiajun Zhao,
- Yiming Mu,
- Weiqing Wang,
- Guang Ning,
- Yufang Bi,
- Yuhong Chen,
- Jieli Lu
Affiliations
- Yuanyue Zhu
- Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- Long Wang
- Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- Lin Lin
- Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- Yanan Huo
- Jiangxi Provincial People’s Hospital Affiliated to Nanchang University, Nanchang, China
- Qin Wan
- The Affiliated Hospital of Luzhou Medical College, Luzhou, China
- Yingfen Qin
- The First Affiliated Hospital of Guangxi Medical University, Nanning, China
- Ruying Hu
- Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China
- Lixin Shi
- Affiliated Hospital of Guiyang Medical University, Guiyang, China
- Qing Su
- Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
- Xuefeng Yu
- Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
- Li Yan
- Sun Yat-sen Memorial Hospital, Sun Yatsen University, Guangzhou, China
- Guijun Qin
- The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Xulei Tang
- The First Hospital of Lanzhou University, Lanzhou, China
- Gang Chen
- Fujian Provincial Hospital, Fujian Medical University, Fuzhou, China
- Shuangyuan Wang
- Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- Hong Lin
- Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- Xueyan Wu
- Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- Chunyan Hu
- Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- Mian Li
- Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- Min Xu
- Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- Yu Xu
- Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- Tiange Wang
- Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- Zhiyun Zhao
- Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- Zhengnan Gao
- Dalian Municipal Central Hospital Affiliated of Dalian Medical University, Dalian, China
- Guixia Wang
- The First Hospital of Jilin University, Changchun, China
- Feixia Shen
- The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
- Xuejiang Gu
- The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
- Zuojie Luo
- The First Affiliated Hospital of Guangxi Medical University, Nanning, China
- Li Chen
- Qilu Hospital of Shandong University, Jinan, China
- Qiang Li
- The Second Affiliated Hospital of Harbin Medical University, Harbin, China
- Zhen Ye
- Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China
- Yinfei Zhang
- Central Hospital of Shanghai Jiading District, Shanghai, China
- Chao Liu
- Jiangsu Province Hospital on Integration of Chinese and Western Medicine, Nanjing, China
- Youmin Wang
- The First Affiliated Hospital of Anhui Medical University, Hefei, China
- Shengli Wu
- Karamay Municipal People’s Hospital, Xinjiang, China
- Tao Yang
- The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
- Huacong Deng
- The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
- Lulu Chen
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
- Tianshu Zeng
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
- Jiajun Zhao
- Shandong Provincial Hospital affiliated to Shandong University, Jinan, China
- Yiming Mu
- Chinese People’s Liberation Army General Hospital, Beijing, China
- Weiqing Wang
- Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- Guang Ning
- Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- Yufang Bi
- Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- Yuhong Chen
- Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- Jieli Lu
- Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- DOI
- https://doi.org/10.5009/gnl230220.e
- Journal volume & issue
-
Vol. 18,
no. 5
pp. 926 – 927
Abstract
Background/Aims: Necrotizing pancreatitis (NP) presents a more severe clinical trajectory and increased mortality compared to edematous pancreatitis. Prompt identification of NP is vital for patient prognosis. A risk prediction model for NP among Chinese patients has been developed and validated to aid in early detection. Methods: A retrospective analysis was performed on 218 patients with acute pancreatitis (AP) to examine the association of various clinical variables with NP. The least absolute shrinkage and selection operator (LASSO) regression was utilized to refine variables and select predictors. Subsequently, a multivariate logistic regression was employed to construct a predictive nomogram. The model's accuracy was validated using bootstrap resampling (n=500) and its calibration assessed via a calibration curve. The model's clinical utility was evaluated through decision curve analysis. Results: Of the 28 potential predictors analyzed in 218 AP patients, the incidence of NP was 25.2%. LASSO regression identified 14 variables, with procalcitonin, triglyceride, white blood cell count at 48 hours post-admission, calcium at 48 hours post-admission, and hematocrit at 48 hours post-admission emerging as independent risk factors for NP. The resulting nomogram accurately predicted NP risk with an area under the curve of 0.822, sensitivity of 82.8%, and specificity of 76.4%. The bootstrap-validated area under the curve remained at 0.822 (95% confidence interval, 0.737 to 0.892). This model exhibited excellent calibration and demonstrated greater predictive efficacy and clinical utility for NP than APACHE II, Ranson, and BISAP. Conclusions: We have developed a prediction nomogram of NP that is of great value in guiding clinical decision.